Mountain Capital Investment Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-13,824
Closed -$1.16M 55
2023
Q4
$1.16M Sell
13,824
-1,160
-8% -$90.3K 0.39% 15
2023
Q3
$1.14M Sell
14,984
-12,901
-46% -$992K 0.43% 12
2023
Q2
$2.17M Sell
27,885
-8,379
-23% -$668K 0.82% 10
2023
Q1
$3.02M Buy
36,264
+4,207
+13% +$348K 1.33% 13
2022
Q4
$2.79M Buy
32,057
+2,385
+8% +$189K 1.27% 14
2022
Q3
$1.96M Buy
29,672
+1,567
+6% +$98.8K 1.03% 22
2022
Q2
$1.76M Buy
28,105
+3,952
+16% +$245K 0.88% 33
2022
Q1
$1.5M Sell
24,153
-1,885
-7% -$120K 0.71% 50
2021
Q4
$1.88M Buy
26,038
+7,605
+41% +$524K 0.85% 28
2021
Q3
$1.25M Buy
18,433
+1,112
+6% +$78.1K 0.66% 53
2021
Q2
$1.17M Buy
17,321
+32
+0.2% +$2.14K 0.54% 53
2021
Q1
$1.12M Buy
17,289
+3,638
+27% +$235K 0.56% 62
2020
Q4
$853K Sell
13,651
-4,142
-23% -$250K 0.51% 65
2020
Q3
$1.15M Buy
+17,793
New +$1.23M 0.74% 49
2017
Q4
Sell
-773
Closed -$63K 175
2017
Q3
$63K Sell
773
-3,425
-82% -$262K 0.06% 97
2017
Q2
$297K Buy
+4,198
New +$279K 0.29% 19

Other funds holding GILD

Mountain Capital Investment Advisors's GILD Position: Q1 2024 in Review

Mountain Capital Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 13,824 shares — an estimated $1.16M sold.

Mountain Capital Investment Advisors first reported a position in GILD in Q2 2017 and held it in 16 quarters. The position peaked at $3.02M in Q1 2023. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Mountain Capital Investment Advisors reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Mountain Capital Investment Advisors sold 13,824 Gilead Sciences shares in Q1 2024, an estimated $1.16M.
  • Mountain Capital Investment Advisors first reported a position in Gilead Sciences in Q2 2017 and held it in 16 quarters.
  • Mountain Capital Investment Advisors's Gilead Sciences position peaked at $3.02M in Q1 2023.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Mountain Capital Investment Advisors's 13F filing for Q1 2024, filed 11 Apr 2024.